GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
ARYX THERAPEUTICS I (ARYX) [hlAlert]

Rating:
Buy ARYX
down 99.96 %

ARYX THERAPEUTICS I (ARYX) rated Buy

Posted on: Tuesday,  Dec 18, 2007  9:25 AM ET by Leerink Swann

Leerink Swann rated Buy ARYX THERAPEUTICS I (OTCBB: ARYX) on 12/18/2007, when the stock price was $8.09.
Since then, ARYX THERAPEUTICS I has lost 99.96% as of 08/27/2015's recent price of $0.00.
If you would have followed this Leerink Swann 's recommendation on ARYX, you would have lost 99.96% of your investment in 2809 days.

ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design(TM) technology to design structurally unique molecules that retain the efficacy of these original drugs but are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these compounds. ARYx currently has three products in Phase 2 clinical trials: ATI-7505 for the treatment of various gastrointestinal disorders, ATI-5923 for the treatment of patients at risk for the formation of dangerous blood clots, and ATI-2042 for the treatment of atrial fibrillation.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/18/2007 9:25 AM Buy
None
8.09
as of 8/27/2015
1 Week up  66.66 %
1 Month up  42.85 %
3 Months up  50.00 %
1 YTD down  -54.54 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy